Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers

被引:31
作者
D'Alonzo, Marta [1 ]
Piva, Eleonora [2 ]
Pecchio, Silvia [1 ]
Liberale, Viola [1 ]
Modaffari, Paola [1 ]
Ponzone, Riccardo [3 ]
Biglia, Nicoletta [1 ]
机构
[1] Umberto I Hosp, Obstet & Gynaecol Unit, Rome, Italy
[2] Univ Turin, St Anna Hosp, Dept Surg Sci, Gynaecol & Obstet 1, Turin, Italy
[3] Candiolo Canc Inst, Dept Gynecol Oncol, Candiolo, Italy
关键词
BRCA; Breast cancer; Ovarian cancer; Prophylactic surgery; Surveillance; HORMONE REPLACEMENT THERAPY; BREAST-CANCER RISK; OVARIAN-CANCER; SALPINGO-OOPHORECTOMY; WOMEN; MASTECTOMY; HEALTH; RECONSTRUCTION; SUSCEPTIBILITY; MANAGEMENT;
D O I
10.1016/j.clbc.2018.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical and instrumental surveillance recommendations and prophylactic breast and ovarian surgery may impact on the quality of life of patients with BRCA 1-2 mutation. A questionnaire was administered to 174 women with confirmed BRCA mutations to evaluate the satisfaction with risk-reduction strategies. Responders show a good level of satisfaction, namely a reduction of the anxiety of cancer risk. Bilateral salpingo-oophorectomy can worsen the quality of life owing to symptoms associated with early menopause. Surveillance programs are deemed useful, and the degree of satisfaction about the prophylactic surgery is generally high. Introduction: BRCA 1 and 2 mutation carriers are invited to follow intensive clinical and instrumental surveillance programs or are offered prophylactic breast and ovarian surgery. These recommendations impact many aspects of their life. This study aims to evaluate the satisfaction with surveillance and prophylactic surgery and the impact of these procedures on the quality of life. Patients and Methods: An anonymous questionnaire was administered to 174 BRCA1-2 mutation carriers. Results: A total of 95% of women comply with the scheduled checks every 6 months. Periodic examinations are considered useful for early diagnosis of breast/ovarian cancer by 91.5% of responders. Among those women who received prophylactic breast surgery, 95% believe that this procedure can reduce cancer risk, but only 65% were completely satisfied by the cosmetic outcome. Among women who underwent prophylactic ovarian surgery, 90.5% would choose it again, mainly owing to a lower degree of concern about ovarian cancer risk. The early onset of menopausal symptoms was the most frequently reported side effects, but only 21% of patients use any treatment to relieve them. Conclusion: Women who follow a surveillance program show a good level of satisfaction, thanks to the lowering of concerns of cancer risk. The degree of satisfaction about the prophylactic surgery is generally high. Risk-reducing mastectomy is usually well-accepted, despite the fact that cosmetic results are not entirely satisfactory. Bilateral salpingo-oophorectomy may impact on quality of life because of the symptoms associated with early surgical menopause, even if it can be treated with hormonal replacement therapies. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E1361 / E1366
页数:6
相关论文
共 36 条
[1]   The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in "previvors" [J].
Alexandre, Mehida ;
Black, Jonathan ;
Whicker, Margaret ;
Minkin, Mary Jane ;
Ratner, Elena .
MATURITAS, 2017, 105 :46-51
[2]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[3]   Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations:: A decision analysis [J].
Armstrong, K ;
Schwartz, JS ;
Randall, T ;
Rubin, SC ;
Weber, B .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1045-1054
[4]   2016 IMS Recommendations on women's midlife health and menopause hormone therapy [J].
Baber, R. J. ;
Panay, N. ;
Fenton, A. .
CLIMACTERIC, 2016, 19 (02) :109-150
[5]   Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers [J].
Berrington de Gonzalez, Amy ;
Berg, Christine D. ;
Visvanathan, Kala ;
Robson, Mark .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (03) :205-209
[6]  
Biglia N, 2018, EUR J CANCER CARE, P27
[7]   Mirtazapine for the treatment of hot flushes in breast cancer survivors: A prospective pilot trial [J].
Biglia, Nicoletta ;
Kubatzki, Franziska ;
Sgandurra, Paola ;
Ponzone, Riccardo ;
Marenco, Davide ;
Sismondi, Piero .
BREAST JOURNAL, 2007, 13 (05) :490-495
[8]   Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study [J].
Biglia, Nicoletta ;
Peano, Elisa ;
Sgandurra, Paola ;
Moggio, Giulia ;
Panuccio, Enrico ;
Migliardi, Marco ;
Ravarino, Nicoletta ;
Ponzone, Riccardo ;
Sismondi, Piero .
GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (06) :404-412
[9]   Patient regrets after bilateral prophylactic mastectomy [J].
Borgen, PI ;
Hill, ADK ;
Tran, KN ;
Van Zee, KJ ;
Massie, MJ ;
Payne, D ;
Biggs, CG .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (07) :603-606
[10]   The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy [J].
Bresser, P. J. C. ;
Seynaeve, C. ;
Van Gool, A. R. ;
Niermeijer, M. F. ;
Duivenvoorden, H. J. ;
van Dooren, S. ;
van Geel, A. N. ;
Menke-Pluijmers, M. B. ;
Klijn, J. G. M. ;
Tibben, A. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) :95-103